🔎 Trials Near Me

Home › Atopic Dermatitis (Eczema) › Georgia

Pag-aaral pangklinika para sa Atopic Dermatitis (Eczema) sa Georgia

9 pag-aaral para sa Atopic Dermatitis (Eczema) ang naghahanap ng mga kalahok sa mga site sa Georgia.

Mga Lungsod sa Georgia

Opisyal na teksto ng pag-aaral (English)

This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment

  • Skin Care Physicians of Georgia - Macon- Site Number : 8400034, Macon
Nagre-recruitObservasyonal na pag-aaral
Edad 12 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07290803

Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

  • Novartis Investigative Site, Atlanta
  • Novartis Investigative Site, Macon
Nagre-recruitPhase 2
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06947993

Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

  • Enveda Investigative Site, Atlanta
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07298395

A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis

  • Investigational Site, Douglasville
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07003425

A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis

  • Hamilton Research, LLC, Alpharetta
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT07223697

A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

  • Georgia Skin & Cancer Center, Savannah
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT07599813

A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis

  • Emory University School Of Medicine - Atlanta /ID# 268832, Atlanta
  • Aeroallergy Research Laboratory /ID# 267247, Savannah
Nagre-recruitPhase 3
Edad 2 hanggang 11 · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT06461897

A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis

  • Leo Pharma Investigational site, Macon
Nagre-recruitPhase 3
6 Months – 11 Years · Lahat ng kasarian · Na-update Hul 7, 2026 · NCT06311682

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

  • Centricity Research Columbus Dermatology /ID# 266529, Columbus
  • Cleaver Medical Group Dermatology /ID# 263788, Dawsonville
Nagre-recruitPhase 3
Edad 18 hanggang 63 · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT06389136

Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.